OCUMETICS TECHNOLOGY CORP (OTC.CA) Stock Price, Forecast & Analysis
Canada - TSX-V:OTC - CA67577H1047 - Common Stock
OTC.CA Key Statistics, Chart & Performance
The current stock price of OTC.CA is 1.16 CAD. In the past month the price decreased by -9.37%. In the past year, price increased by 197.44%.
OTC.CA Latest News, Press Relases and Analysis
OTC.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BLCO.CA | BAUSCH + LOMB CORP | 35.35 | 7.51B | ||
| ZEN.CA | ZENTEK LTD | N/A | 122.66M |
Related stock screener links
About OTC.CA
Company Profile
Ocumetics Technology Corp. engages in the development of bio lenses to completely eliminate the need for corrective lenses, especially for people over 45 years of age. The company is headquartered in Calgary, Alberta. The company went IPO on 2018-08-29. The firm specializes in adaptive lens designs. The firm is focused on developing an accommodating intraocular lens. The Ocumetics lens is an expandable intraocular lens that fits within the natural lens compartment of the eye with the objective of eliminating the need for corrective lenses. The company is designed to allow the eye’s natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lens’s suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipient’s eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.
Company Info
OCUMETICS TECHNOLOGY CORP
1250, 639 - 5th Avenue S.W.
Calgary ALBERTA CA
Employees: 0
Phone: 14036507718
OCUMETICS TECHNOLOGY CORP / OTC.CA FAQ
What does OCUMETICS TECHNOLOGY CORP do?
Ocumetics Technology Corp. engages in the development of bio lenses to completely eliminate the need for corrective lenses, especially for people over 45 years of age. The company is headquartered in Calgary, Alberta. The company went IPO on 2018-08-29. The firm specializes in adaptive lens designs. The firm is focused on developing an accommodating intraocular lens. The Ocumetics lens is an expandable intraocular lens that fits within the natural lens compartment of the eye with the objective of eliminating the need for corrective lenses. The company is designed to allow the eye’s natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lens’s suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipient’s eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.
What is the stock price of OCUMETICS TECHNOLOGY CORP today?
The current stock price of OTC.CA is 1.16 CAD.
Does OTC stock pay dividends?
OTC.CA does not pay a dividend.
How is the ChartMill rating for OCUMETICS TECHNOLOGY CORP?
OTC.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What sector and industry does OCUMETICS TECHNOLOGY CORP belong to?
OCUMETICS TECHNOLOGY CORP (OTC.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Should I buy OTC stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OTC.CA.
What is OCUMETICS TECHNOLOGY CORP worth?
OCUMETICS TECHNOLOGY CORP (OTC.CA) has a market capitalization of 145.87M CAD. This makes OTC.CA a Micro Cap stock.
OTC.CA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to OTC.CA. When comparing the yearly performance of all stocks, OTC.CA is one of the better performing stocks in the market, outperforming 96.39% of all stocks.
OTC.CA Financial Highlights
Over the last trailing twelve months OTC.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -28.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -334.37% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |